C07D 277/56
Carbon atoms having three bonds to hetero atoms with at the most
Official title: Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
C07D277/56 (Carbon atoms having three bonds to hetero atoms with at the most) appears on 1,111 US grants and 1,145 published applications in this corpus.
Search patents in C07D- Granted patents
- 1,111
- Published applications
- 1,145
- Assignees
- 552
- Inventors
- 3,764
- Latest grant
- 8 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 9 | 0 |
| 1977 | 14 | 0 |
| 1978 | 3 | 0 |
| 1979 | 8 | 0 |
| 1980 | 8 | 0 |
| 1981 | 8 | 0 |
| 1982 | 6 | 0 |
| 1983 | 14 | 0 |
| 1984 | 10 | 0 |
| 1985 | 7 | 0 |
| 1986 | 9 | 0 |
| 1987 | 3 | 0 |
| 1988 | 8 | 0 |
| 1989 | 4 | 0 |
| 1990 | 16 | 0 |
| 1991 | 14 | 0 |
| 1992 | 15 | 0 |
| 1993 | 21 | 0 |
| 1994 | 12 | 0 |
| 1995 | 9 | 0 |
| 1996 | 22 | 0 |
| 1997 | 28 | 0 |
| 1998 | 19 | 0 |
| 1999 | 17 | 0 |
| 2000 | 13 | 0 |
| 2001 | 27 | 1 |
| 2002 | 24 | 30 |
| 2003 | 28 | 38 |
| 2004 | 20 | 64 |
| 2005 | 20 | 54 |
| 2006 | 23 | 46 |
| 2007 | 35 | 55 |
| 2008 | 37 | 57 |
| 2009 | 31 | 62 |
| 2010 | 48 | 71 |
| 2011 | 32 | 64 |
| 2012 | 52 | 43 |
| 2013 | 44 | 63 |
| 2014 | 66 | 63 |
| 2015 | 53 | 60 |
| 2016 | 43 | 48 |
| 2017 | 43 | 40 |
| 2018 | 27 | 38 |
| 2019 | 33 | 28 |
| 2020 | 22 | 39 |
| 2021 | 23 | 37 |
| 2022 | 18 | 35 |
| 2023 | 17 | 35 |
| 2024 | 15 | 34 |
| 2025 | 23 | 27 |
| 2026 | 10 | 13 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Arylsulfonamides as orexin receptor agonists8 Sep 2026US 12,729,178 B2Research Triangle Institute
- 5-membered heteroaryl carboxamide compounds for treatment of HBV16 Jun 2026US 12,655,130 B2Assembly Biosciences, Inc.
- Carbonohydrazonoyl dicyanide compounds comprising 2 or more aryl or heteroaryl connected via linker and use thereof9 Jun 2026US 12,649,723 B2Korea Institute of Science and Technology
- Modifier of four-membered ring derivative, preparation method and application thereof5 May 2026US 12,617,759 B2Jiangsu Hansoh Pharmaceutical Group Co., Ltd.
- Refining method31 Mar 2026US 12,590,075 B2NGK Insulators, Ltd.
- Biarylamide derivatives and their use as pkmyt1 inhibitors1 Oct 2026US 2026/0297042 A1Cancer Research Technology Limited
- 5-membered heteroaryl carboxamide compounds for treatment of hbv17 Sep 2026US 2026/0274823 A1Assembly Biosciences, Inc.
- Compound serving as ddr1 kinase inhibitor, and medicine20 Aug 2026US 2026/0242343 A1Nippon Shinyaku Co., Ltd.
- Electrolyte Additive, Electrolyte for Lithium Secondary Battery Including the Same and Lithium Secondary Battery20 Aug 2026US 2026/0245963 A1LG Energy Solution, Ltd.
- Adar1 inhibitors and methods of using the same16 Jul 2026US 2026/0200890 A1Aten Porus Lifesciences Pvt. Ltd.
Most cited
By later US patents
- Retroviral protease inhibiting compounds159US 5,142,056 AAbbott Laboratories · 1992
- Aryl carbonyl derivatives as therapeutic agents152US 7,384,967 B2Novo Nordisk A/S · 2008
- N-indanyl carboxamide derivative and agricultural/horticultural fungicide containing the derivative as active ingredient141US 4,914,097 AMitsubishi Kasei Corporation · 1990
- Cyclic protein tyrosine kinase inhibitors134US 6,596,746 B1Bristol-Myers Squibb Company · 2003
- Thiazoles and oxazoles useful as modulators of ATP-binding cassette transporters130US 7,846,951 B2Vertex Pharmaceuticals Incorporated · 2010